NEW YORK (GenomeWeb News) – Cancer Genetics has filed a preliminary prospectus to offer $15 million in a public offering of its stock.

In a Form S-1 filed with the US Securities and Exchange Commission on Wednesday, the Rutherford, NJ-based cancer diagnostics firm said that it anticipates net proceeds of $13.5 million from the offering. It has not priced the shares or said how many shares it plans to offer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.